Tamara Aleksic

1.0k total citations
18 papers, 786 citations indexed

About

Tamara Aleksic is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Tamara Aleksic has authored 18 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Tamara Aleksic's work include Growth Hormone and Insulin-like Growth Factors (6 papers), Glioma Diagnosis and Treatment (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Tamara Aleksic is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (6 papers), Glioma Diagnosis and Treatment (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Tamara Aleksic collaborates with scholars based in United Kingdom, Germany and Austria. Tamara Aleksic's co-authors include Valentine M. Macaulay, Shan Gao, Meenali Chitnis, Andrew Protheroe, Paul Haluska, Thomas Wirth, Bernd Baumann, Olga V. Perestenko, Stephan M. Feller and Mark Howarth and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Oncogene.

In The Last Decade

Tamara Aleksic

18 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamara Aleksic United Kingdom 15 454 258 245 219 130 18 786
Cinzia Puppin Italy 23 782 1.7× 360 1.4× 369 1.5× 220 1.0× 99 0.8× 46 1.2k
Elena Tirrò Italy 19 423 0.9× 204 0.8× 261 1.1× 207 0.9× 40 0.3× 48 1.0k
Hisato Hara Japan 17 223 0.5× 256 1.0× 349 1.4× 198 0.9× 183 1.4× 60 875
Federica Torricelli Italy 18 471 1.0× 131 0.5× 208 0.8× 212 1.0× 77 0.6× 80 1.0k
Michele Massimino Italy 22 496 1.1× 256 1.0× 297 1.2× 249 1.1× 46 0.4× 64 1.2k
Dongfeng Niu China 13 306 0.7× 124 0.5× 166 0.7× 83 0.4× 95 0.7× 29 601
Aizhen Xiao United States 15 393 0.9× 110 0.4× 189 0.8× 253 1.2× 61 0.5× 21 773
Jung Hun Song South Korea 10 384 0.8× 321 1.2× 285 1.2× 92 0.4× 40 0.3× 10 757
Jin Hyung Heo South Korea 16 528 1.2× 99 0.4× 111 0.5× 374 1.7× 121 0.9× 38 860
Elaina Cajulis United States 11 432 1.0× 135 0.5× 301 1.2× 126 0.6× 80 0.6× 23 838

Countries citing papers authored by Tamara Aleksic

Since Specialization
Citations

This map shows the geographic impact of Tamara Aleksic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara Aleksic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara Aleksic more than expected).

Fields of papers citing papers by Tamara Aleksic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara Aleksic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara Aleksic. The network helps show where Tamara Aleksic may publish in the future.

Co-authorship network of co-authors of Tamara Aleksic

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara Aleksic. A scholar is included among the top collaborators of Tamara Aleksic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara Aleksic. Tamara Aleksic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Qureishi, Ali, Guillaume Rieunier, Ketan Shah, et al.. (2019). Radioresistant laryngeal cancers upregulate type 1 IGF receptor and exhibit increased cellular dependence on IGF and EGF signalling. Clinical Otolaryngology. 44(6). 1026–1036. 5 indexed citations
2.
Rieunier, Guillaume, et al.. (2019). Type 1 IGF receptor associates with adverse outcome and cellular radioresistance in paediatric high-grade glioma. British Journal of Cancer. 122(5). 624–629. 18 indexed citations
3.
Aleksic, Tamara, Nicki Gray, Xiaoning Wu, et al.. (2018). Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor Stage. Cancer Research. 78(13). 3497–3509. 50 indexed citations
4.
Aleksic, Tamara, Clare Verrill, Richard J. Bryant, et al.. (2017). IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancer. British Journal of Cancer. 117(11). 1600–1606. 38 indexed citations
5.
Aleksic, Tamara, Lisa Browning, Rachel R. Phillips, et al.. (2016). Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR. Frontiers in Oncology. 6. 98–98. 31 indexed citations
6.
Aleksic, Tamara, et al.. (2016). Improved Immunohistochemical Detection of Type 1 Insulin-Like Growth Factor Receptor in Human Tumors. Oxford University Research Archive (ORA) (University of Oxford). 2(1). 3 indexed citations
7.
Aleksic, Tamara, Ketan Shah, Chengcheng Han, et al.. (2015). IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer. Carcinogenesis. 36(6). 648–655. 42 indexed citations
8.
Aleksic, Tamara, Shan Gao, Sophia X. Pfister, et al.. (2015). IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide. Oncotarget. 6(37). 39877–39890. 23 indexed citations
9.
Aleksic, Tamara, et al.. (2014). Can we unlock the potential of IGF-1R inhibition in cancer therapy?. Cancer Treatment Reviews. 40(9). 1096–1105. 102 indexed citations
11.
Gao, Shan, et al.. (2014). Suppression of homologous recombination sensitizes human tumor cells to IGF‐1R inhibition. International Journal of Cancer. 136(12). 2961–2966. 14 indexed citations
13.
Aleksic, Tamara, Meenali Chitnis, Olga V. Perestenko, et al.. (2010). Type 1 Insulin-like Growth Factor Receptor Translocates to the Nucleus of Human Tumor Cells. Cancer Research. 70(16). 6412–6419. 169 indexed citations
14.
Aleksic, Tamara & Stephan M. Feller. (2008). Gamma-secretase inhibition combined with platinum compounds enhances cell death in a large subset of colorectal cancer cells. Cell Communication and Signaling. 6(1). 8–8. 38 indexed citations
15.
Naumović, Radomir, Gordana Basta-Jovanović, Zoran Miloradović, et al.. (2007). Effects of Rapamycin on Active Heymann Nephritis. American Journal of Nephrology. 27(4). 379–389. 16 indexed citations
16.
Aleksic, Tamara, Denis Krndija, Götz von Wichert, et al.. (2007). CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation. Oncogene. 26(40). 5939–5949. 21 indexed citations
17.
Baumann, Bernd, Martin Wagner, Tamara Aleksic, et al.. (2007). Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo. Journal of Clinical Investigation. 117(6). 1502–1513. 103 indexed citations
18.
Aleksic, Tamara, et al.. (2006). Cellular immune reaction in the pancreas is induced by constitutively active I B kinase-2. Gut. 56(2). 227–236. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026